Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person10
Panacea Applications Limited
Company · 10516149
WYNN DEVELOPMENTS LIMITED
Company · 10743837
P.M.C. CONSTRUCTION AND DEVELOPMENT SERVICES LIMITED
Company · 01675790
Cranfield Management Development Limited
Company · 02760241
WESTCOMBE DEVELOPMENTS LIMITED
Company · 11235987
R2I SEMICONDUCTOR APPLICATIONS LIMITED
Company · 08208909
PROVIDENCE DEVELOPMENTS LIMITED
Company · 05382541
PANATTONI UK DEVELOPMENTS LIMITED
Company · 10892613
EDUCATIONAL DEVELOPMENT CORP
Company
BESA Publications Limited
Company · 03034318
Primary record17
Titan Acquisition Corp. filed 8-K
Item 7.01 Regulation FD Disclosure. Attached as Exhibit 99.1 to this Current Report on Form 8-K is an investor presentation dated November 2026 (the “Investor Presentation”), for use by Titan Acquisition Corp, a Cayman I
Innventure, Inc. filed SCHEDULE 13D/A
0002041777-26-000006.txt : 20261020 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0002041777-26-000001 0002041777 XXXXXXXX LIVE 4 Common Stock 10/19/2026 true 0002001557 45784M108 Innventure, Inc. 6900 TAVISTOCK
Innventure, Inc. filed SCHEDULE 13D/A
0002041777-26-000005.txt : 20261019 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0002041777-26-000001 0002041777 XXXXXXXX LIVE 3 Common Stock 10/19/2026 true 0002001557 45784M108 Innventure, Inc. 6900 TAVISTOCK
ELI LILLY & Co filed SCHEDULE 13D
pursuant to Rule 424(b)(4) of the Securities Act of 1933, as amended, on October 9, 2026. Common Stock, par value $0.0001 per share TRex Bio, Inc. C/O TREX BIO, INC. 269 EAST GRAND AVENUE SUITE 300 SOUTH SAN FRANCISCO CA
Gogoro Inc. filed SCHEDULE 13D
(the "Commission" or "SEC") on behalf of Ruen Hua Dyeing & Weaving Co., Ltd., a Taiwan company ("Ruen Hua" or the "Reporting Person"). The Issuer's Ordinary Shares are listed on the Nasdaq Capital Market under the symbol
Innventure, Inc. filed 8-K
Item 8.01 Other Events. On October 12, 2026, Accelsius Holdings LLC ( Accelsius ), a subsidiary of Innventure, Inc. (the Company ), issued a press release announcing that it has upgraded its Springdale lab and facility i
City of Bradford Metropolitan District Council awarded £33,050 to J C APPLICATIONS DEVELOPMENT LIMITED
City of Bradford Metropolitan District Council awarded a contract to J C APPLICATIONS DEVELOPMENT LIMITED worth £33,050 on 2026-10-09. Contract: Insurance Claims Handling. Claims Management Software. Procured using GClou
ArriVent BioPharma, Inc. filed SCHEDULE 13D/A
(the "SEC") on February 5, 2024 and amended by Amendment No. 1 thereto filed with the SEC on August 13, 2025. This Amendment No. 2 is being filed to report that as a result of the transactions described in Item 5 below,
Transportation & Logistics Systems, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Transportation and Logistics Systems, Inc. (OTCID: TLSS), ( TLSS or the Company ), a publicly traded holding company, announced that, on September 22, 2026, the Compa
Braveheart Bio, Inc. filed SCHEDULE 13D/A
(the "SEC") on August 18, 2026. This Amendment No. 1 is being filed to report that the percentage of outstanding shares of common stock of the Issuer, par value $0.0001 per share ("Shares") that the Reporting Persons may
C3is Inc. filed SCHEDULE 13D/A
0001193125-26-374929.txt : 20260828 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001876581 XXXXXXXX LIVE 13 Common Stock, par value $0.01 per share 08/26/2026 false 0001951067 Y18284409 C3is Inc. 331 Kifissias
Titan Acquisition Corp. filed 8-K
Item 7.01 Regulation FD Disclosure. Attached as Exhibit 99.1 to this Current Report on Form 8-K is an investor presentation dated August 2026 (the “Investor Presentation”), for use by Titan Acquisition Corp, a Cayman Isl
Transportation & Logistics Systems, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Transportation and Logistics Systems, Inc. (OTCID: TLSS), (“TLSS” or the “Company”), a publicly traded holding company, announced that, on August 19, 2026, the Compan
SILVER BOW MINING CORP. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement On August 21, 2026, Silver Bow Mining Corp. (the Company ) entered into an asset purchase agreement (the APA ) with and among Silver Bow Tunnels Corp., a Montana corpo
Ensysce Biosciences, Inc. filed SCHEDULE 13D/A
("SEC") on August 13, 2026. 4.See Disclosure in Items 2 and 5 of this Schedule 13D. Common Stock, par value $0.0001 per share Ensysce Biosciences, Inc. 7946 Ivanhoe Avenue Suite 201 La Jolla CA 92037 This amended stateme
MBX Biosciences, Inc. filed SCHEDULE 13D/A
(the "SEC") on September 23, 2024 and amended by Amendment No. 1 thereto filed with the SEC on September 30, 2025 and Amendment No. 2 thereto filed with the SEC on February 11, 2026. This Amendment No. 3 is being filed t
2023 ETF Series Trust filed SCHEDULE 13D/A
0001542826-26-000006.txt : 20260807 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001542826-26-000003 0001542826 XXXXXXXX LIVE 1 Harrison Street Infrastructure Active ETF 01/30/2026 false 0001969674 900934795 20